Related Experiment Videos
[Cost-effectiveness of screening for amblyopia].
1Augenklinik, Ludwig-Maximilians-Universität, München. Aljoscha.Neubauer@med.uni-muenchen.de
Klinische Monatsblatter Fur Augenheilkunde
|February 19, 2005
Summary
Amblyopia screening programs are cost-effective, offering a good return on investment for public health. Early detection and treatment improve vision outcomes and quality of life.
Area of Science:
- Ophthalmology
- Public Health
- Health Economics
Context:
- Amblyopia screening program effectiveness is debated.
- Cost-effectiveness data for amblyopia screening is limited.
Purpose:
- To determine the cost-effectiveness of amblyopia screening programs.
- To compare the costs of screening and treatment to other therapies.
Summary:
- Literature review identified key variables: amblyopia incidence (approx. 2%), screening sensitivity (60-90%), and therapy effectiveness (60% achieve >20/40 vision).
- The incremental cost-effectiveness ratio (ICER) for screening and treatment is €7684/QALY, comparable to other accepted therapies.
- Sensitivity analysis showed ICERs ranging from €24,700 to €57,633/QALY under various scenarios.
Impact:
- Amblyopia screening meets cost-effectiveness criteria.
- Provides valuable data for healthcare policy decisions regarding pediatric vision screening.
- Supports the integration of cost-effectiveness analysis in public health initiatives.